Vimarsana
Biggest News Aggregation in the World

Ankeet Bhatt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ankeet Bhatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ankeet Bhatt Today - Breaking & Trending Today

Experts' Perspectives: Top Story in Heart Failure for 2023 - Vimarsana News

Experts' Perspectives: Top Story in Heart Failure for 2023

A group of 9 experts in heart failure, ranging from leading trialists to early career clinicians, provide perspective on what they see as the biggest news in heart failure from 2023.

HCPLive - Clinical news for connected physicians - Vimarsana News

HCPLive - Clinical news for connected physicians

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

Determining Cost-Effectiveness of Sacubitril/Valsartan in Heart Failure, with Ankeet Bhatt, MD, MBA - Vimarsana News

Determining Cost-Effectiveness of Sacubitril/Valsartan in Heart Failure, with Ankeet Bhatt, MD, MBA

Ankeet Bhatt, MD, MBA provides additional perspective on a recent study examining the cost-effectiveness and health impact of sacubitril/valsartan use at different thresholds of ejection fraction.

The Prospect of SGLT1/2i in Heart Failure: Cardiologists Await FDA Decision on Sotagliflozin - Vimarsana News

The Prospect of SGLT1/2i in Heart Failure: Cardiologists Await FDA Decision on Sotagliflozin

Ahead of the May 27, 2023 PDUFA date, the HCPLive Cardiology editorial team spoke to a group of cardiologists to capture their perspective of the potential role of sotagliflozin.